100 related articles for article (PubMed ID: 11920453)
1. Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma.
Israel O; Mor M; Epelbaum R; Frenkel A; Haim N; Dann EJ; Gaitini D; Bar-Shalom R; Kolodny GM; Front D
Cancer; 2002 Feb; 94(4):873-8. PubMed ID: 11920453
[TBL] [Abstract][Full Text] [Related]
2. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
[TBL] [Abstract][Full Text] [Related]
4. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
[TBL] [Abstract][Full Text] [Related]
5. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
6. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma.
Tuli MM; Al-Shemmari SH; Ameen RM; Al-Muhanadi S; Al-Huda FA; Ballani N; Khoshi M; Al-Enezi F; Bajciova V; Mottl H
Clin Lymphoma; 2004 Jun; 5(1):56-61. PubMed ID: 15245609
[TBL] [Abstract][Full Text] [Related]
7. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
8. Localized non-Hodgkin lymphoma involving the thyroid gland.
Ha CS; Shadle KM; Medeiros LJ; Wilder RB; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Feb; 91(4):629-35. PubMed ID: 11241227
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
11. Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?
Lee SH; Yoo KH; Sung KW; Ko YH; Lee JW; Koo HH
Pediatr Blood Cancer; 2013 Nov; 60(11):1842-7. PubMed ID: 23857875
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
15. Tl-201 and Ga-67 scintigraphy in non-Hodgkin's lymphoma.
Mansberg R; Wadhwa SS; Mansberg V
Clin Nucl Med; 1999 Apr; 24(4):239-42. PubMed ID: 10466518
[TBL] [Abstract][Full Text] [Related]
16. Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Sarris AH; Papadimitrakopoulou V; Dimopoulos MA; Smith T; Pugh W; Ha CS; McLaughlin P; Callender D; Cox J; Cabanillas F
Leuk Lymphoma; 1997 Jun; 26(1-2):49-56. PubMed ID: 9250787
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the response to treatment and the prognosis of patients with aggressive lymphomas treated with chemotherapy followed by involved-field radiotherapy: radiographic assessment.
Sasaki S; Shikama N; Koiwai K; Kadoya M
Jpn J Clin Oncol; 2008 Jan; 38(1):43-8. PubMed ID: 18258714
[TBL] [Abstract][Full Text] [Related]
18. High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma.
Fang S; Repo H; Joensuu H; Orpana A; Salven P
Eur J Cancer; 2011 Jul; 47(11):1708-16. PubMed ID: 21439815
[TBL] [Abstract][Full Text] [Related]
19. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital.
Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM
Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
